| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.19 | 9e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.084 | 0.09 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.072 | 0.1 |